5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseaseHR+/HER2- Breast CancerRecruitingPhase 32026-09-28NCT07492641
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 12026-09-28NCT07414836
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid TumorsNeoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 12026-08-24NCT06803680
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter SystemAneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorderActive, not recruitingNot applicable2026-08-17NCT04195568
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 12026-07-09NCT06625593